Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Post-Approved Phase III Study of 1-LV/5FU [leucovorin/fluorouracil] Therapy.

Trial Profile

Post-Approved Phase III Study of 1-LV/5FU [leucovorin/fluorouracil] Therapy.

Phase of Trial: Phase III

Latest Information Update: 12 Oct 2009

At a glance

  • Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Gimeracil/oteracil/tegafur
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2009 Primary endpoint 'Overall Survival duration' has been met.
    • 12 Oct 2009 Results have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
    • 18 Aug 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top